Abstract
e20045 Background: Elevated lactate dehydrogenase (LDH) is a known negative prognostic marker in patients (pts) with metastatic melanoma (MM) and may predict lack of response to anti-PD-1/PD-L1 age...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
